News

Early Data Suggest Roche's NXT007 May Have The Potential To Provide Haemostatic Normalisation In People With Haemophilia A
Positive phase I/II data presented at the 2025 International Society on Thrombosis and Haemostasis (ISTH) Congress show NXT007 ...